Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 3 Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07225309
What this trial is testing

Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Who this might be right for
Breast CancerProstate CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center 300
Testing effectiveness (Phase 2)Ended earlyNCT04971187
What this trial is testing

Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00005814
What this trial is testing

Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Not applicableNo Longer AvailableNCT04137822
What this trial is testing

Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreatic CancerPancreatic Cancer Stage IV+1 more
Impatients N.V. trading as myTomorrows
Testing effectiveness (Phase 2)Ended earlyNCT00849251
What this trial is testing

Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
University of Washington 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT05010629
What this trial is testing

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Who this might be right for
Salivary Gland CancerRecurrent Salivary Gland CancerMetastatic Cancer+1 more
Glenn J. Hanna 32
Large-scale testing (Phase 3)Ended earlyNCT05329545
What this trial is testing

Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)

Who this might be right for
High Grade Serous Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Mersana Therapeutics 20
Not applicableUnknownNCT00416377
What this trial is testing

Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Cancer and Leukaemia Group 353
Early research (Phase 1)Study completedNCT00003819
What this trial is testing

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT07042919
What this trial is testing

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaCirrhosisStage III Hepatocellular Carcinoma AJCC v8+1 more
Devalingam Mahalingam 59
Large-scale testing (Phase 3)Looking for participantsNCT07365241
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie 531
Testing effectiveness (Phase 2)Study completedNCT01660451
What this trial is testing

Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-Hodgkin
Bayer 227
Testing effectiveness (Phase 2)Study completedNCT00107445
What this trial is testing

EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer

Who this might be right for
Primary Peritoneal Cavity CancerStage I Endometrial CarcinomaStage I Ovarian Epithelial Cancer+13 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Study completedNCT01001377
What this trial is testing

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Amgen 1,010
Large-scale testing (Phase 3)Ended earlyNCT01956812
What this trial is testing

Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic Cancer
Gilead Sciences 334
Not applicableStudy completedNCT02209012
What this trial is testing

Twelve Month Follow-Up of CP0108

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc. 206
Large-scale testing (Phase 3)Study completedNCT00110019
What this trial is testing

Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Mucosal MelanomaRecurrent MelanomaStage IIIA Skin Melanoma+3 more
National Cancer Institute (NCI) 823
Testing effectiveness (Phase 2)Ended earlyNCT02959554
What this trial is testing

Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control

Who this might be right for
Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 49
Testing effectiveness (Phase 2)Looking for participantsNCT07516366
What this trial is testing

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Who this might be right for
Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8Stage III Renal Cell Cancer AJCC v8+1 more
National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Study completedNCT03607656
What this trial is testing

The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer

Who this might be right for
Gastric Cancer Stage IIIBGastric Cancer Stage IIIC
Shanghai University of Traditional Chinese Medicine 270
Next Page